Cargando…

Botulinum Toxin Type A for the Treatment of Auriculotemporal Neuralgia—A Case Series

Auriculotemporal neuralgia is a rare pain disorder in which anesthetic nerve blockade is usually effective but not always resolutive. Botulinum toxin type A has proven to be effective in treating neuropathic pain, and patients with auriculotemporal neuralgia could also benefit from this treatment. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tereshko, Yan, Belgrado, Enrico, Lettieri, Christian, Gigli, Gian Luigi, Valente, Mariarosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141838/ https://www.ncbi.nlm.nih.gov/pubmed/37104212 http://dx.doi.org/10.3390/toxins15040274

Ejemplares similares

Botulinum toxin type A for genitofemoral neuralgia: A case report
por: Tereshko, Yan, et al.
Publicado: (2023)

The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
por: Tereshko, Yan, et al.
Publicado: (2023)

Nummular headache: a case report of remission following ketogenic diet and botulinum toxin type A injections
por: Tereshko, Yan, et al.
Publicado: (2023)

Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report
por: Tereshko, Yan, et al.
Publicado: (2022)

Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine
por: Valente, Mariarosaria, et al.
Publicado: (2021)

The Effect of Three Different Ketogenic Diet Protocols on Migraine and Fatigue in Chronic and High-Frequency Episodic Migraine: A Pilot Study
por: Tereshko, Yan, et al.
Publicado: (2023)

Refractory facial pain attributed to auriculotemporal neuralgia
por: Stuginski-Barbosa, Juliana, et al.
Publicado: (2012)

2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study
por: Tereshko, Yan, et al.
Publicado: (2023)

Guillain–Barré syndrome following Covid-19 immunization: a report of two cases
por: Bax, Francesco, et al.
Publicado: (2021)

Synovial cyst of temporomandibular joint, a potential etiology for auriculotemporal neuralgia?
por: Ansari, H, et al.
Publicado: (2013)

Auriculotemporal Carcinoma - A Retrospective Case Series
por: Yetiser, Sertac, et al.
Publicado: (2022)

A Case Report of Pulsed Radiofrequency Plus Suboccipital Injection of the Greater Occipital Nerve: An Easier Target for Treatment of Cluster Headache
por: Belgrado, Enrico, et al.
Publicado: (2021)

New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review
por: Tereshko, Yan, et al.
Publicado: (2022)

The Possible Precipitating Role of SARS-CoV-2 in a Case of Late-Onset Hemichorea Due to a Hyperosmolar Hyperglycemic State: Case Report and Brief Literature Review
por: Sperotto, Roberto, et al.
Publicado: (2023)

Botulinum as a Toxin for Treating Post-herpetic Neuralgia
por: DING, Xu-Dong, et al.
Publicado: (2017)

Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia
por: Kayani, Abdul Mueez Alam, et al.
Publicado: (2022)

Auriculotemporal Nerve Syndrome
por: Yoshida, Hirofumi, et al.
Publicado: (2017)

Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
por: Verma, Gaurav
Publicado: (2013)

Management of Trigeminal Neuralgia with Botulinum Toxin Type A: Report of Two Cases
por: Pearl, Craig, et al.
Publicado: (2022)

Stress Hyperglycemia Does Not Affect Clinical Outcome of Diabetic Patients Receiving Intravenous Thrombolysis for Acute Ischemic Stroke
por: Merlino, Giovanni, et al.
Publicado: (2022)

Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports
por: Belgrado, Enrico, et al.
Publicado: (2022)

Efficacy of Botulinum Toxin Type A in Trigeminal Neuralgia in a South Asian Cohort
por: Caldera, Manjula Chandragomi, et al.
Publicado: (2018)

Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
por: Shehata, Hatem S, et al.
Publicado: (2013)

Subcutaneous Injection of Botulinum Toxin-A in Postherpetic Neuralgia During Pregnancy
por: Jain, Pratik, et al.
Publicado: (2017)

Imaging of auriculotemporal nerve perineural spread
por: Chan, Michael, et al.
Publicado: (2013)

Auriculotemporal syndrome following forceps delivery
por: Edgerley, Sarah, et al.
Publicado: (2023)

Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review
por: Hu, Yong, et al.
Publicado: (2013)

Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes
por: Valente, Mariarosaria, et al.
Publicado: (2022)

The Present and Future of Optic Pathway Glioma Therapy
por: Dal Bello, Simone, et al.
Publicado: (2023)

The Efficacy of Intradermal Injection of Botulinum Toxin in Patients with Post-Herpetic Neuralgia
por: Emad, M R, et al.
Publicado: (2011)

Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up
por: Türk Börü, Ülkü, et al.
Publicado: (2017)

Effects of Intradermal Botulinum Toxin Injections on Herpes Zoster Related Neuralgia
por: Peng, Fen, et al.
Publicado: (2023)

Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis
por: Meng, Fan, et al.
Publicado: (2018)

New-onset status epilepticus in SARS-CoV-2 infection: a case series
por: Belluzzo, Marco, et al.
Publicado: (2021)

Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect
por: Wu, Shouyi, et al.
Publicado: (2019)

Auriculotemporal Frey syndrome not associated with surgery or diabetes: systematic review
por: Betti, Céline, et al.
Publicado: (2022)

Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia
por: Liu, Jing, et al.
Publicado: (2018)

Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study
por: Pellitteri, Gaia, et al.
Publicado: (2022)

The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review
por: Rubis, Anton, et al.
Publicado: (2020)

Botulinum Toxin Type-A (Botulax(®)) Treatment in Patients with Intractable Chronic Occipital Neuralgia: A Pilot Study
por: Kim, Hyeyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kodvfm23djhv93g2ruv9do4qii